3644 results for «2694»
3644 results
TMVIV - TMVIR and its challenges
23 May 2025 – From EuroPCR 2025
Explore the challenges and innovations in transcatheter mitral valve-in-valve and valve-in-ring procedures. This session presents alternative access routes, management of paraannular compromise, and complex cases involving ECMO support and unexpected outcomes, offering valuable insights into advanced mitral interventions.
PCI for complex bifurcation disease - LIVE Case
23 May 2025 – From EuroPCR 2025
A 60-year-old male patient presented with an inferior STEMI one month ago, which was treated with RCA and LCx PCI. He was referred for LAD/diagonal PCI. The LV function was reduced (EF 45 %). The team performed a DK crush PCI, guided by IVUS.
LIVE Educational Case...
When strange things happen, CTO and complications
23 May 2025 – From EuroPCR 2025
This session addresses complications and unexpected challenges encountered in chronic total occlusion (CTO) interventions. Learn from cases involving retrieval of stuck wires, coronary perforations, and strategies to manage complex and unusual procedural difficulties.
Through decisions in complex left main PCI - Left main restenosis
23 May 2025 – From EuroPCR 2025
Gain comprehensive understanding of left main restenosis mechanisms, diagnostic evaluation, and treatment options. This session includes case presentations with angiographic and intracoronary imaging assessments, explores the role of imaging in management decisions, and reviews therapeutic strategies including repeat stenting, drug-eluting balloons, and coronary artery bypass grafting.
Challenges and complications in coronary interventions
23 May 2025 – From EuroPCR 2025
Discuss real-world challenges and complications in coronary interventions including heavily calcified LAD PCI, cardiac crisis management, and rare intramural hematoma cases. The session emphasizes the importance of IVUS guidance and operator expertise in complex scenarios.
Which device for which patient: DES, BRS or DCB?
22 May 2025 – From EuroPCR 2025
This session provides comprehensive guidance on selecting the appropriate device—DES, BRS, or DCB—for individual patients and lesions. It examines patient and lesion characteristics, strengths and limitations of each device type, and regional considerations, illustrated by case presentations demonstrating practical device choice and resolution.
Stent failure: don't guess, just see!
22 May 2025 – From EuroPCR 2025
Investigate causes and imaging-based solutions for stent failure in this session. Topics include management of refractory stent underexpansion using lithotripsy or stent ablation, OCT perspectives on iatrogenic aortic dissection during PCI for in-stent restenosis, and analyses of bioresorbable scaffold failure. Gain insights into complex stenting techniques...
M-TEER around the world
08 Feb 2025 – From PCR Tokyo Valves 2025
Explore the latest insights and advancements in the field of Mitral Transcatheter Edge-to-Edge Repair (M-TEER) from around the world. Discover a new anatomical risk score for predicting procedural outcomes, two-year outcomes from the MiCLASP study, the impact of regurgitant volume to left atrial volume ratio on...
TAVI complications: hemolytic anemia, prosthetic valve endocarditis & stroke
08 Feb 2025 – From PCR Tokyo Valves 2025
Gain valuable insights into the management of complications associated with Transcatheter Aortic Valve Implantation (TAVI). Discover the latest evidence on hemolytic anemia, the predictive value of the hemoglobin to creatinine ratio, outcomes of transcarotid TAVI, a case study on prosthetic valve endocarditis, the role of diastolic...
M-TEER difficult situation: small mitral valves, P2 prolapse & leaflet degeneration
08 Feb 2025 – From PCR Tokyo Valves 2025
Explore a series of challenging cases in Mitral Transcatheter Edge-to-Edge Repair (M-TEER), highlighting the versatility and adaptability of this technique. Discover how M-TEER can be successfully applied in patients with extremely small mitral valves, P2 prolapse supported by chordae from the posterior papillary muscle, wide prolapse...
TAVI complications cases - Part 1
08 Feb 2025 – From PCR Tokyo Valves 2025
Dive into the world of TAVI complications in this comprehensive session. Explore a range of challenging cases, including bailout implantation of an embolized self-expandable valve, ascending aortic dissection, coronary embolization, cardiac tamponade, and annular rupture. Gain insights into the management strategies and specialized techniques employed to...
Late-Breaking Trial session
08 Feb 2025 – From PCR Tokyo Valves 2025
Discover the latest insights from pivotal studies in this PCR Tokyo Valves 2025 LBT session. Explore early feasibility updates from the AltaValve trial, in-hospital outcomes comparing surgical vs. percutaneous intervention in aortic stenosis with coronary artery disease from the JROAD-DPC data, and procedural results from the...
Basic imaging and procedural steps for T-TEER
08 Feb 2025 – From PCR Tokyo Valves 2025
Don’t miss this PCR Tokyo Valves 2025 session, where experts provide a comprehensive guide to T-TEER. Explore the basic anatomy and mechanisms essential for procedural planning and learn how to effectively image the tricuspid valve during T-TEER using 3D echocardiography and intracardiac echocardiogram. This session walks...
TAVI unplugged: multidisciplinary insights on roles and teamwork
08 Feb 2025 – From PCR Tokyo Valves 2025
Successful TAVI procedures rely on more than just technical expertise—they require seamless teamwork across specialties. In this session PCR Tokyo Valves 2025, discover the crucial roles of radiologists and nurses in the preoperative and intraoperative phases of TAVI. Through live case analysis and shared experiences, gain...
The 2025 top Japanese abstracts
08 Feb 2025 – From PCR Tokyo Valves 2025
Dive into the latest cutting-edge research from Japan, as this session presents the top abstracts from 2025. Explore the impact of billowing on treatment outcomes in secondary mitral regurgitation, the mortality risk associated with severity of thinness in TAVR patients, the prognostic impact of delirium severity...
TAV-in-SAV - Part 1
08 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the complex world of TAV-in-SAV (Transcatheter Aortic Valve-in-Surgical Aortic Valve) in this comprehensive session. Explore various case studies, including valve-in-valve TAVI in a patient with structural valve deterioration, a successful case of balloon-assisted BASILICA for TAV-in-TAV, and TAVI after valve sparing aortic replacement. Gain...
TAVI access issues
08 Feb 2025 – From PCR Tokyo Valves 2025
Dive into the challenges and innovative solutions surrounding TAVI access issues in this comprehensive session. Discover a one-step operation of transcarotid TAVI and PDA occlusion, a bailout case of transfemoral TAVI through a severely bent and calcified aorta, the role of transcaval access in hostile peripheral...
How to optimise the patient outcomes - Key considerations for the small body population
08 Feb 2025 – From PCR Tokyo Valves 2025
Explore the latest strategies for optimizing outcomes in Asian and international patients with small body size. Through case presentations, surgical experiences, and the latest data on device performance, gain valuable insights into treating aortic stenosis more effectively. Discover how these advancements can enhance patient care and...
Maximising the potential of MitraClip in TEER therapy
08 Feb 2025 – From PCR Tokyo Valves 2025
Explore the latest advancements in TEER therapy with this PCR Tokyo Valves 2025 session dedicated to MitraClip. Through expert-led case discussions, gain a deeper understanding of complex scenarios, including restricted posterior leaflet in functional mitral regurgitation, commissure lesion (A3P3), and MitraClip combined with Amulet.
This session also...
Mastering techniques from basic to complex - TEER for functional mitral regurgitation
07 Feb 2025 – From PCR Tokyo Valves 2025
Explore the complexities of functional mitral regurgitation (FMR) in this PCR Tokyo Valves 2025 session, where experts delve into key anatomical challenges and advanced TEER techniques. Learn why surgery remains the first-line treatment for atrial FMR, particularly when concomitant tricuspid regurgitation is present, and when radiofrequency...
